Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
After announcing the state would initiate coverage of GLP-1s to combat obesity in September 2022 as part of their state employee health plan, the state reversed course and in January 2025 announced it was opting to end that coverage beginning July 1, 2025
Hims & Hers just learned a hard lesson in the "vertical integration" of Big Pharma and the FDA
A careful review of your medical history helps determine whether you have risk factors that need to be addressed before starting therapy
One-third of those patients saw their weight fall into a healthy range, while two-thirds dropped below the threshold for obesity, according to The Wall Street Journal
These views and opinions do not necessarily represent those of Antaros Medical
US$ 28.36
US$ 23.26
US$ 23.28
US$ 25.12
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
